$2.1645
-0.0355[-1.61%]
At close: Apr 24
$2.1645
0[0.00%]
PreMarket: 5:51PM EDT
Lexaria Bioscience
(NASDAQ:LEXX)Lexaria Bioscience Stock (NASDAQ:LEXX), Earnings Estimates, EPS, and Revenue
Lexaria Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 9
EPS
$-0.060
Quarterly Revenue
$145K
Annual Revenue
(as of Feb 29)
(as of Feb 29)
$404.7K
Analyze the earnings history of Lexaria Bioscience using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | PM | LEXX | Q3 | -$0.37 | — | — | — | $93.15K | — | — | — | Get Alert |
| 04/09/2024 | PM | LEXX | Q2 | -$0.22 | -$0.10 | -$0.06 | 40.00% | $35.02K | — | $145.00K | — | Get Alert |
| 01/12/2024 | PM | LEXX | Q1 | -$0.30 | — | -$0.13 | — | $101.48K | — | $151.28K | — | Get Alert |
| 11/20/2023 | AM | LEXX | Q4 | -$0.24 | -$0.13 | -$0.12 | 7.69% | $111.15K | $170.00K | $0.00 | -100.00% | Get Alert |
| 07/14/2023 | PM | LEXX | Q3 | -$0.41 | — | -$0.37 | — | $99.72K | — | $93.15K | — | Get Alert |
| 04/14/2023 | PM | LEXX | Q2 | -$0.25 | — | -$0.22 | — | $30.65K | — | $35.02K | — | Get Alert |
| 01/17/2023 | PM | LEXX | Q1 | -$0.35 | — | -$0.30 | — | $13.88K | — | $101.48K | — | Get Alert |
| 11/28/2022 | AM | LEXX | Q4 | -$0.25 | -$0.21 | -$0.24 | -14.29% | $31.02K | — | $111.15K | — | Get Alert |
| 07/14/2022 | PM | LEXX | Q3 | -$0.40 | -$0.21 | -$0.41 | -95.24% | $204.06K | — | $99.72K | — | Get Alert |
| 04/11/2022 | AM | LEXX | Q2 | -$0.27 | — | -$0.25 | — | $192.01K | — | $30.65K | — | Get Alert |
| 01/14/2022 | PM | LEXX | Q1 | -$0.24 | — | -$0.35 | — | $295.66K | — | $13.88K | — | Get Alert |
| 11/29/2021 | AM | LEXX | Q4 | — | — | -$0.25 | — | — | — | $31.02K | — | Get Alert |
| 07/15/2021 | AM | LEXX | Q3 | — | — | -$0.40 | — | — | — | $204.06K | — | Get Alert |
| 04/14/2021 | AM | LEXX | Q2 | — | — | -$0.27 | — | — | — | $192.01K | — | Get Alert |
| 01/14/2021 | AM | LEXX | Q1 | — | — | -$0.24 | — | — | — | $295.66K | — | Get Alert |
FAQ
When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?
Lexaria Bioscience (LEXX) is scheduled to report earnings on July 12, 2024. The last reported earnings were for reported on April 9, 2024 for Q2.
What were the latest earnings per share (EPS) for Lexaria Bioscience (NASDAQ:LEXX)?
The Actual EPS was $-0.06, which beat the estimate of $-0.10.
What were Lexaria Bioscience’s (NASDAQ:LEXX) revenues?
The Actual Revenue was $145K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.